WiseTech Global Stock and 2 Australian Shares Trading Below Estimated Fair Value

With energy prices swinging, inflation signals mixed across regions and central banks rethinking policy, investors are paying closer attention to what really sits behind earnings and cash flow. The Undervalued Stocks Based On Cash Flows screener focuses on companies where discounted cash flow analysis suggests prices sit below fair value, so you are not relying only on short term sentiment. In a world of uneven housing data, shifting bond yields and fresh trade tariffs, that focus on cash flow and valuation can help you stay grounded. This article highlights 3 stocks from the screener that stand out today.

Mesoblast (ASX:MSB)

Overview: Mesoblast develops regenerative medicine therapies based on mesenchymal lineage cells, aiming to treat severe inflammatory, cardiovascular and pain conditions such as graft versus host disease, inflammatory bowel disease, chronic heart failure and chronic low back pain. The company advances these cell therapies through late stage clinical trials and partnerships with larger pharmaceutical groups.

Operations: Mesoblast currently generates about US$65.4 million in revenue from developing its cell technology platform for commercialization.

Market Cap: A$2.9b

Mesoblast provides exposure to late stage cell therapies, with a focus on severe conditions such as steroid refractory graft versus host disease and chronic low back pain, supported by partnerships with groups such as Tasly, JCR Pharmaceuticals and Grünenthal. Analysts expect strong improvements in earnings and revenue, and the stock is trading below one estimate of fair value based on discounted cash flows. However, the business is still loss making, has a high P/S ratio and relies on external borrowing. Recent updates around Phase 3 trial progress, regulatory designations and rising product sales illustrate how quickly the situation could change, while also highlighting the level of execution risk that remains for long term holders.

Mesoblast is priced below one discounted cash flow estimate, yet remains loss making with a high P/S ratio and funding needs. Compare that to the DCF valuation analysis for Mesoblast to see what the market might be missing.

Lynas Rare Earths (ASX:LYC)

Overview: Lynas Rare Earths is a rare earths miner and processor, running the Mt Weld mine in Western Australia and downstream plants in Kalgoorlie and Malaysia to supply key materials such as neodymium, praseodymium and other light and heavy rare earths used in magnets and high tech applications.

Operations: Lynas Rare Earths currently generates about A$715.9 million in revenue from its Rare Earth Operations segment.

Market Cap: A$14.9b

Lynas Rare Earths is positioned within the broader effort to secure non Chinese rare earth supply, alongside rising demand from electrification, government support and long term contracts like the JS Link magnet partnership running through to 2038. At the same time, reliance on external borrowing, a relatively narrow product set and fresh Malaysian parliamentary scrutiny of its Pentagon deal contribute to regulatory and funding risk. The combination of earnings quality, margins and growth forecasts on one side and policy, execution and technology shifts on the other may lead different investors to reach different conclusions about the overall risk reward profile.

Lynas Rare Earths sits at the crossroads of earnings quality and policy risk, and the market reaction may not fully reflect that tension. Get the full context in the analysis report for Lynas Rare Earths.

WiseTech Global (ASX:WTC)

Overview: WiseTech Global develops and sells cloud-based software that helps freight forwarders, customs brokers and other logistics providers manage the movement and storage of goods and data across global supply chains. Its CargoWise platform and related tools support tasks like forwarding, customs clearance, warehousing and transport planning for customers across the Americas, Asia Pacific and EMEA.

Operations: WiseTech Global generates revenue from logistics software solutions across the Americas (US$450.7 million), Asia Pacific (US$254.8 million) and Europe, Middle East and Africa (US$364.2 million).

Market Cap: A$10.0b

WiseTech Global sits at an interesting point for investors who care about both cash flow and quality. Its logistics software is deeply embedded in global supply chains, recurring SaaS revenue is supported by industry wide digitization, and the CargoWise commercial reset plus the E2open acquisition offers a larger addressable market and more ways to monetize customer workflows. At the same time, a rich P/E, slowing organic growth, higher leverage from the A$3b debt facility and complex integration work mean execution really matters. Recent governance changes, including a new independent chair and a separate Chief Innovation Officer role for co founder Richard White, add another layer to the story that investors should understand before deciding how comfortable they are with the risk return trade off here.

WiseTech Global’s expanding reach into global logistics and the E2open deal could be masking a very different earnings and risk profile than headlines suggest. It is worth weighing that against the analyst forecasts for WiseTech Global

The three stocks covered here are just a starting sample from the full Undervalued Stocks Based On Cash Flows idea. Our screener has surfaced 34 more companies where discounted cash flow analysis and company narratives line up in interesting ways through the Undervalued Stocks Based On Cash Flows screener. Use Simply Wall St to identify and analyze the specific catalysts, cash flow trends and storylines that matter to you so you can focus on your own highest conviction opportunities.

Take Control of Your Investment Journey

If Lynas Rare Earths or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives Before They Fly?

Fresh stock ideas can move from quiet to breakout before most investors even look twice. Use these focused lists while the information is under the radar for now, act now.

• Target steady income potential with a curated group of high yield opportunities through the 6 dividend fortresses so you are not chasing payouts after momentum has already taken off.
• Spot early movers in frontier computing by scanning the 26 quantum computing stocks before capital floods in and makes the obvious opportunities harder to catch at appealing levels.
• Lock onto fast growing infrastructure suppliers by reviewing the 55 AI infrastructure stocks while attention is still catching up to the demand for data centers and AI hardware.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com